American Heart Journal · 2023 · 16 citations · 17 references
MedicineChronic Disease ControlChronic Disease PreventionDiabetologyDisease PreventionPreventive CardiologyCardiovascular DiseaseCardiovascular Disease PreventionCardiovascular Risk ReductionDiabetes MellitusGlycemic ControlRisk Factor ReductionCardiac Risk ReductionCardiometabolic Risk ManagementCardiovascular Disease ManagementCardiovascular Risk ManagementCardiovascular Risk StratificationDiabetes-associated Cardiac RiskType 2 Diabetes Risk Reduction
17
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman, Christoph Wanner, John M. Lachin et al. · New England Journal of Medicine · 2015 · 12K citations · Full text
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen et al. · New England Journal of Medicine · 2016 · 7.3K citations · Full text
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
Stefan D. Anker, Javed Butler, Gerasimos Filippatos et al. · New England Journal of Medicine · 2021 · 4.6K citations · Full text
Medicine, Cardiology, Pharmacology +14
Economic Costs of Diabetes in the U.S. in 2002
Paul Hogan, Plamen Nikolov · Diabetes Care · 2003 · 4.2K citations
Standards of Medical Care in Diabetes 2014
Majmaah Journal of Health Sciences · 2014 · 1.5K citations · Full text